Key takeaways
- Peptides are short amino acid chains, commonly about 2 to 50 residues, joined by amide (peptide) bonds and written from N-terminus to C-terminus.
- Solid-phase peptide synthesis builds the chain from C to N on a resin, so small per-step coupling losses add up to deletion sequences in longer peptides.
- TFA cleavage usually leaves peptides as TFA salts, so powder weight, HPLC purity and net peptide content are three different numbers.
- A research use only label states intended laboratory use; it does not make a substance legal for human use, so check the TGA and the current Poisons Standard.
Most people meet peptides twice. The first time is in an undergraduate biochemistry lecture, where they are a stepping stone on the way to proteins. The second is at the bench, when a vial of white powder arrives with a sequence on the label and a certificate of analysis in the inbox. This guide covers what a peptide is, how a synthetic research peptide is actually made, why laboratories bother with them, and what the words “research use only” do and do not mean for an Australian lab.
Peptides, briefly
A peptide is a short chain of amino acids joined by peptide bonds. Each bond is an amide linkage formed between the carboxyl group of one amino acid and the amino group of the next, with a molecule of water lost in the process. The chain has direction: a free amino group at one end (the N-terminus) and a free carboxyl group at the other (the C-terminus). Sequences are written N to C by convention, so “YGGFM” and “MFGGY” are different molecules.
There is no hard line between a peptide and a protein. A common working rule puts peptides at roughly 2 to 50 residues, with anything longer and folded into a stable three-dimensional structure called a protein.
| Feature | Small molecule | Peptide | Protein |
|---|---|---|---|
| Typical size | Under about 900 Da | Roughly 2 to 50 residues | Usually more than 50 residues |
| Usual production route | Organic synthesis | Chemical synthesis (mostly solid-phase) | Recombinant expression in cells |
| Main identity checks | NMR, mass spectrometry | Mass spectrometry, HPLC | Mass spectrometry, gel electrophoresis, activity assays |
| Common weak points | Varies with chemistry | Hydrolysis, oxidation, deamidation, aggregation | Unfolding, aggregation, proteolysis |
How a research peptide is built
Solid-phase synthesis
Nearly every catalogue peptide is made by solid-phase peptide synthesis (SPPS), the method R. Bruce Merrifield introduced in the early 1960s and for which he received the 1984 Nobel Prize in Chemistry. The first amino acid is anchored by its C-terminus to an insoluble resin bead, and the chain is grown one residue at a time towards the N-terminus. That is the opposite direction to a ribosome, which builds from N to C.
Each cycle has the same rhythm: remove the temporary protecting group from the growing chain, wash, couple the next protected amino acid with an activating reagent, wash again. Because the peptide stays attached to the resin, excess reagents and by-products are simply rinsed away. No purification is needed between steps, which is what made the method automatable.
The catch is arithmetic. If every coupling runs at 99 per cent, a 30-residue peptide still finishes with only about three-quarters of the chains being full length. The rest are deletion and truncation sequences that closely resemble the target. Longer sequences, and stretches of bulky or aggregation-prone residues, make the problem worse.
Fmoc and Boc chemistry
Two protecting-group strategies dominate. In Fmoc chemistry, the amino group of each incoming residue carries a fluorenylmethyloxycarbonyl group that is removed with a mild base, usually piperidine, while side chains are protected with acid-labile groups. In the older Boc chemistry, the tert-butyloxycarbonyl group is removed with acid, and final cleavage traditionally requires hydrogen fluoride, which needs specialised equipment. Fmoc chemistry is now the default for most commercial work because its conditions are milder, although Boc is still chosen for some difficult sequences.
Cleavage and the counter-ion question
Once the chain is complete, a cleavage cocktail based on trifluoroacetic acid (TFA) releases the peptide from the resin and strips the side-chain protecting groups in one step. Scavengers such as water and triisopropylsilane are added to trap the reactive carbocations released during deprotection, which would otherwise attach themselves to sensitive residues like tryptophan, methionine and cysteine.
A practical consequence: peptides with basic groups usually come out of this process as TFA salts. The counter-ion adds mass that is not peptide, so the weight of powder in a vial is not the same as the amount of peptide in it. Where residual TFA could interfere with an assay, labs can request or perform an exchange to acetate or hydrochloride salts.
Purification, analysis and lyophilisation
The crude product is purified by preparative reversed-phase HPLC, typically on a C18 column with a water and acetonitrile gradient containing a little TFA. Clean fractions are pooled. Each step controls something different:
| Step | What it controls | What can still go wrong |
|---|---|---|
| Chain assembly (SPPS) | Sequence and length | Deletion sequences, racemisation, aspartimide formation |
| TFA cleavage | Removal of resin and protecting groups | Incomplete deprotection, modified side chains |
| Preparative HPLC | Removal of closely related impurities | Co-eluting impurities with similar hydrophobicity |
| Analytical HPLC and mass spectrometry | Purity figure and confirmation of molecular mass | HPLC alone cannot confirm identity, and mass spectrometry alone does not give a purity figure |
| Lyophilisation | Removal of water and solvent | Moisture uptake if vials are opened cold or left unsealed |
Analytical HPLC gives a purity percentage, usually from absorbance near 214 to 220 nm where the peptide bond absorbs. Mass spectrometry confirms that the main peak has the expected molecular mass. The two answer different questions, and a good certificate reports both. Our guides on peptide purity testing and reading a certificate of analysis go through the details, including why HPLC purity and net peptide content are not the same number.
Finally, the pooled fractions are freeze-dried. Lyophilisation removes water by sublimation under vacuum, leaving a light, fluffy powder. With water largely gone, the reactions that degrade peptides in solution, such as hydrolysis and deamidation of asparagine, slow dramatically. Dry powder is not invulnerable, though. Lyophilised peptides are often hygroscopic, and a cold vial opened straight from the freezer will pull condensation onto the cake. How lyophilised peptides are stored covers temperature, light and the habit of letting vials warm to room temperature before opening.
Why laboratories work with synthetic peptides
The appeal is control. A synthetic peptide is a defined chemical entity with a known sequence, which is not something you can say about a tissue extract.
- Receptor and binding studies. Many signalling molecules are peptides or act through peptide-binding receptors. Synthetic analogues let researchers change one residue at a time and measure the effect on binding in cell-based or membrane assays, building structure–activity relationships residue by residue.
- Enzyme assays. Short sequences make convenient substrates for proteases and kinases, and can carry fluorescent or chromogenic labels for readout.
- Immunology and epitope mapping. Overlapping peptide sets are used to locate which stretch of a protein an antibody recognises.
- Reproducibility. Lots made to the same specification should behave alike, and the analytical data give reviewers something to check.
- Breadth of models. Chemistry makes modifications easy that biology does not: D-amino acids, non-natural residues, N-terminal acetylation, C-terminal amidation, cyclisation and isotope labels.
None of this makes peptides forgiving. Sequences rich in hydrophobic residues can be stubborn to dissolve, and cysteine-containing peptides may form disulfide-linked dimers on standing. The handling best-practice guide is worth reading before the first reconstitution.
What “research use only” means in Australia
“Research use only” (RUO) is a statement of intended use. It tells the buyer the material is supplied for laboratory research, such as in-vitro assays and analytical work, and has not been assessed or approved for any therapeutic, diagnostic or personal purpose.
It is not a legal loophole. An RUO label does not make a substance lawful to use in people, and it does not override Australian regulation. The Therapeutic Goods Administration (TGA) regulates therapeutic goods, and many peptides are listed in the Poisons Standard (the SUSMP), which is given effect through state and territory legislation. Scheduling decisions change over time, so the reliable approach is to check the current Poisons Standard and TGA guidance for each compound rather than relying on a supplier’s summary, including ours.
An RUO label describes what a supplier intends. It does not describe what the law permits.
RUO material also sits inside your institution’s own obligations, from chemical registers to record-keeping. Our RUO standards article covers this in more detail.
A short checklist for a new peptide
- Confirm the sequence, modifications and salt form on the label match what the experiment needs.
- Read the certificate: HPLC purity, mass spectrometry result and, where given, net peptide content.
- Check the batch number on the vial against the batch on the certificate.
- Let the vial reach room temperature before opening, and weigh out only what you need.
- Choose a solvent based on the sequence’s charge and hydrophobicity, and test solubility on a small portion first.
- Aliquot any stock solution to avoid repeated freeze-thaw cycles, and label aliquots with sequence, concentration, date and batch.
Where to go next
If this is your first time working with synthetic peptides, the most useful habit to build early is reading the analytical data before the experiment, not after an odd result. Aussie Peptide Co supplies peptides from Melbourne strictly for in-vitro laboratory research. Keep the TGA and the Poisons Standard bookmarked for the regulatory side.
References & further reading
- Bruce Merrifield: Nobel Lecture (Nobel Prize in Chemistry 1984) NobelPrize.org
- Advances in Fmoc solid-phase peptide synthesis Behrendt, White and Offer, Journal of Peptide Science (PubMed Central)
- HPLC Analysis and Purification of Peptides Mant, Chen, Yan, Popa et al., Peptide Characterization and Application Protocols (PubMed Central)
- The Shape and Structure of Proteins Alberts et al., Molecular Biology of the Cell (NCBI Bookshelf)
Frequently asked questions
Both are chains of amino acids joined by peptide bonds, and the boundary between them is a convention rather than a rule. Peptides are usually taken to be about 2 to 50 residues long and are mostly made by chemical synthesis. Proteins are longer, fold into a defined three-dimensional structure and are normally produced by recombinant expression in cells.
Most peptides are cleaved from the synthesis resin with trifluoroacetic acid, and TFA is also common in the HPLC purification buffers. Basic groups on the peptide pair with trifluoroacetate, so the dried product is a salt. The counter-ion adds weight that is not peptide. If residual TFA could affect an assay, exchange to an acetate or hydrochloride salt is an option.
Freeze-drying removes water by sublimation under vacuum. In solution, peptides break down through reactions such as hydrolysis and deamidation, and these slow a great deal once the water is gone, so the dry powder keeps far better. The powder often takes up moisture easily, though. Let a cold vial warm to room temperature before opening it, so condensation does not form on the contents.
No. Research use only is a supplier's statement that the material is intended for laboratory research. It is not TGA approval and it does not make any substance lawful for human use. The TGA regulates therapeutic goods, and many peptides are listed in the Poisons Standard, which the states and territories apply. Check the current Poisons Standard and TGA guidance for each compound.
Our in-house team writes laboratory-focused guides on peptide documentation, testing, storage and handling. Content is reviewed against published analytical practice and is provided strictly for research use.
